Search research articles
Contact Us
Filters
Showing results (81-90 of 168) with videos related to
Page
of 17
Sort By:
Antibiotics (Basel, Switzerland)
|
September 27, 2025
Rapid Emergence of Cefiderocol Resistance Associated with Mutation of <i>EnvZ</i> Gene in a VIM-Producing ST307 <i>Klebsiella pneumoniae</i> Strain
Simone Ambretti, Benedetta Secci, Raul Cetatean, et al.
Current Heart Failure Reports
|
October 7, 2020
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia
Milo Gatti, Emanuel Raschi, Elisabetta Poluzzi, et al.
Antibiotics (Basel, Switzerland)
|
April 28, 2023
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
Milo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
International Journal of Antimicrobial Agents
|
May 16, 2023
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF)
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
International Journal of Antimicrobial Agents
|
February 22, 2023
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections
Milo Gatti, Vincent H Tam, Paolo Gaibani, et al.
The Journal of Antimicrobial Chemotherapy
|
February 10, 2026
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of orthotopic liver transplant recipients
Milo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
International Journal of Antimicrobial Agents
|
October 1, 2023
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia
Milo Gatti, Matteo Rinaldi, Paolo Gaibani, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 2024
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients
Milo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Journal of Anesthesia, Analgesia and Critical Care
|
December 3, 2025
Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infections
Milo Gatti, Pierantonio Grimaldi, Matteo Rinaldi, et al.
Jac-Antimicrobial Resistance
|
May 7, 2025
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing <i>Klebsiella pneumoniae</i> otomastoiditis
Stella Babich, Pier Giorgio Cojutti, Milo Gatti, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 168) with videos related to
Sort By:
Page
of 17
Antibiotics (Basel, Switzerland)
|
September 27, 2025
Rapid Emergence of Cefiderocol Resistance Associated with Mutation of <i>EnvZ</i> Gene in a VIM-Producing ST307 <i>Klebsiella pneumoniae</i> Strain
Simone Ambretti, Benedetta Secci, Raul Cetatean, et al.
Current Heart Failure Reports
|
October 7, 2020
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia
Milo Gatti, Emanuel Raschi, Elisabetta Poluzzi, et al.
Antibiotics (Basel, Switzerland)
|
April 28, 2023
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
Milo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
International Journal of Antimicrobial Agents
|
May 16, 2023
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF)
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
International Journal of Antimicrobial Agents
|
February 22, 2023
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections
Milo Gatti, Vincent H Tam, Paolo Gaibani, et al.
The Journal of Antimicrobial Chemotherapy
|
February 10, 2026
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of orthotopic liver transplant recipients
Milo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
International Journal of Antimicrobial Agents
|
October 1, 2023
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia
Milo Gatti, Matteo Rinaldi, Paolo Gaibani, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 2024
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients
Milo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Journal of Anesthesia, Analgesia and Critical Care
|
December 3, 2025
Validation of a predictive risk score of aggressive PK/PD target non-attainment with continuous infusion piperacillin/tazobactam or meropenem in critically ill patients having documented Gram-negative infections
Milo Gatti, Pierantonio Grimaldi, Matteo Rinaldi, et al.
Jac-Antimicrobial Resistance
|
May 7, 2025
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing <i>Klebsiella pneumoniae</i> otomastoiditis
Stella Babich, Pier Giorgio Cojutti, Milo Gatti, et al.
Page
of 17